BiologIC Technologieshas received an investment from CPI Enterprises. CPI is a recognised leader in bioprocessing innovation founded with a clear vision – to stimulate impactful investment into deep technology businesses. Cambridge UK: BiologIC Technologies (“BiologIC”), the biocomputer company, announces today that it has received an investment from CPI Enterprises. BiologIC is the inventor of the […]
Twist to report fiscal Q4 and full year 2022 financial results before market Friday, November 18, and host a conference call at 8:00 a.m. Eastern Time SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today addressed a misleading short-seller […]
The developer of the AI-powered, connected lab platform will use the funding to expand its operations in the life sciences technologies market. CAMBRIDGE, Mass. – Elemental Machines, a developer of the LabOps Intelligence Platform for labs around the world, has raised $41 million in a Series B funding round led by Sageview Capital and co-led […]
Additional investment triggered by throughput-related milestone PROVIDENCE, R.I. — Nabsys, the pioneer in electronic whole-genome mapping, announced today that it has received an additional $13 million from Hitachi High-Tech as part of an expanded equity round now totaling $38 million. The expanded equity investment was triggered as a result of a technical milestone achieved in relation to its […]
Investment to Underpin Position as Europe’s Leading Real World Data Provider and Enabler of Personalized Precision Medicine ZURICH, Switzerland — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has closed a CHF 20 million (approx. USD 20 million) financing round. This growth equity financing was led by new investor Jolt Capital (HQ […]
MENLO PARK, CA – LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis. The funding allows LevitasBio to accelerate its commercial success through the development […]
Funds to support scale-up, including continued development of AI-augmented knowledge discovery platform, the e[datascientist]™, and continued international expansion Platform business focused on bridging the current ‘translation gap’, addressing critical bottlenecks in the industrial application of microbiome science – from soil, to plant, to farm, to fork, to human, to animals, and environmental health Round led […]
Funding led by Patient Square Capital follows successful launch of groundbreaking system that delivers highest-resolution view of subcellular, single-molecule, spatial biology MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included […]
Univercells, a global life science company providing all-round solutions for biologics manufacturing, has raised € 44 million through the first close of its Series D financing round. In addition to the support of existing private and public shareholders, Univercells is very pleased to welcome prominent new investors from Belgium and the United States. Brussels (Belgium) […]
The company uses computational design to control the function of RNA for molecular detection and therapeutics. SEATTLE — RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led by Notation Capital and Divergent Capital to continue its groundbreaking work in the use of RNA as a detection and therapeutic platform. RNA […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
